NAD+ anticancer vs oncogenic: Clearing Up Misconceptions About NAD+’s Cellular Energy Supply
NAD+ anticancer vs oncogenic is one of the most debated questions in metabolic health research. Is NAD+ a cancer promoter or a tumor suppressor? This hotly debated question has sparked widespread confusion among consumers. As the core coenzyme driving all cellular energy metabolism, NAD+ governs mitochondrial ATP synthesis, DNA damage repair, and systemic immune regulation. […]